Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul David Bach currently holds 952,089 shares of Genesis Healthcare, Inc. (GEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul David Bach has been a net seller of GEN stock. They have purchased $0 and sold $108.7K worth of shares.
Paul David Bach's most recent insider trade was on May 15, 2021, when they sold 66,598 shares at $0.24 per share.
Paul David Bach serves as Executive at Genesis Healthcare, Inc. (GEN). They have executed 16 insider transactions totaling $108.7K over their tenure at the company.
Paul David Bach holds the position of Executive at Genesis Healthcare, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Paul David Bach has shown a selling trading pattern, with $0 in total purchases and $108.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul David Bach was on Jun 5, 2018, when they sold $22.2K worth of GEN shares. This transaction involved 10,131 shares at $2.19 per share.
Paul David Bach currently owns 952,089 shares of Genesis Healthcare, Inc. (GEN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul David Bach's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul David Bach has 16 Form 4 filings on record as an insider at Genesis Healthcare, Inc..
Set alerts for Paul David Bach and 40,000+ other insiders.